Edrophonium test
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Edrophonium test. Edrophonium is a short-acting acetylcholine esterase inhibitor. Fully referenced neurology checklist.
Procedure
- Edrophonium is a short-acting acetylcholine esterase inhibitor
- It is administered by intravenous injection
- The test is carried out under cardiac and blood pressure monitoring
- Atropine is kept available to reverse bradycardia
- Infrared oculography may improve the sensitivity in ocular MG
Risks
Locked: subscribe to see this section.
Causes of a false positive test
Locked: subscribe to see this section.
Synonym
Locked: subscribe to see this section.
References
- Thanvi BR, Lo TCN. Update on myasthenia gravis. Postgrad Med J 2004; 80:690–700.
- Jayam Trouth A, Dabi A, Solieman N, Kurukumbi M, Kalyanam J. Myasthenia gravis: a review. Autoimmune Dis 2012; 2012:874680.
- Tsunoda K, Fujimaki Y, Morita Y. Detectable voice change with the edrophonium test in laryngeal myasthenia gravis. J Int Med Res 2017; 45:1466-1469.
- Williams IM, Dickinson P, Sum AC. Edrophonium test in myasthenia: quantitative oculography. Clin Exp Neurol 1986; 22:1-12.
- Oh SJ, Cho HK. Edrophonium responsiveness not necessarily diagnostic of myasthenia gravis. Muscle Nerve 1990; 13:187-191.
- And 2 more. Subscribe to see the full list